Global Avian Influenza Vaccines Market Growth 2020-2025

Publisher Name :
Date: 16-Sep-2020
No. of pages: 135

According to this study, over the next five years the Avian Influenza Vaccines market will register a 2.5%% CAGR in terms of revenue, the global market size will reach $ 117.3 million by 2025, from $ 106.3 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Avian Influenza Vaccines business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Avian Influenza Vaccines market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Avian Influenza Vaccines, covering the supply chain analysis, impact assessment to the Avian Influenza Vaccines market size growth rate in several scenarios, and the measures to be undertaken by Avian Influenza Vaccines companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

- Type H5

- Type H9

- Other

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

- Chicken

- Duck & Goose

- Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- United States

- Canada

- Mexico

- Brazil

- APAC

- China

- Japan

- Korea

- Southeast Asia

- India

- Australia

- Europe

- Germany

- France

- UK

- Italy

- Russia

- Middle East & Africa

- Egypt

- South Africa

- Israel

- Turkey

- GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- Merial

- CEVA

- Elanco (Lohmann )

- Merck Animal Health

- Zoetis

- Avimex Animal Health

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Avian Influenza Vaccines consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

- To understand the structure of Avian Influenza Vaccines market by identifying its various subsegments.

- Focuses on the key global Avian Influenza Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Avian Influenza Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Avian Influenza Vaccines submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Avian Influenza Vaccines Market Growth 2020-2025

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Avian Influenza Vaccines Consumption 2015-2025
2.1.2 Avian Influenza Vaccines Consumption CAGR by Region
2.2 Avian Influenza Vaccines Segment by Type
2.2.1 Type H5
2.2.2 Type H9
2.2.3 Other
2.3 Avian Influenza Vaccines Consumption by Type
2.3.1 Global Avian Influenza Vaccines Consumption Market Share by Type (2015-2020)
2.3.2 Global Avian Influenza Vaccines Revenue and Market Share by Type (2015-2020)
2.3.3 Global Avian Influenza Vaccines Sale Price by Type (2015-2020)
2.4 Avian Influenza Vaccines Segment by Application
2.4.1 Chicken
2.4.2 Duck & Goose
2.4.3 Other
2.5 Avian Influenza Vaccines Consumption by Application
2.5.1 Global Avian Influenza Vaccines Consumption Market Share by Type (2015-2020)
2.5.2 Global Avian Influenza Vaccines Value and Market Share by Type (2015-2020)
2.5.3 Global Avian Influenza Vaccines Sale Price by Type (2015-2020)

3 Global Avian Influenza Vaccines by Company
3.1 Global Avian Influenza Vaccines Sales Market Share by Company
3.1.1 Global Avian Influenza Vaccines Sales by Company (2018-2020)
3.1.2 Global Avian Influenza Vaccines Sales Market Share by Company (2018-2020)
3.2 Global Avian Influenza Vaccines Revenue Market Share by Company
3.2.1 Global Avian Influenza Vaccines Revenue by Company (2018-2020)
3.2.2 Global Avian Influenza Vaccines Revenue Market Share by Company (2018-2020)
3.3 Global Avian Influenza Vaccines Sale Price by Company
3.4 Global Avian Influenza Vaccines Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Avian Influenza Vaccines Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Avian Influenza Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Avian Influenza Vaccines by Regions
4.1 Avian Influenza Vaccines by Regions
4.2 Americas Avian Influenza Vaccines Consumption Growth
4.3 APAC Avian Influenza Vaccines Consumption Growth
4.4 Europe Avian Influenza Vaccines Consumption Growth
4.5 Middle East & Africa Avian Influenza Vaccines Consumption Growth

5 Americas
5.1 Americas Avian Influenza Vaccines Consumption by Countries
5.1.1 Americas Avian Influenza Vaccines Consumption by Countries (2015-2020)
5.1.2 Americas Avian Influenza Vaccines Value by Countries (2015-2020)
5.2 Americas Avian Influenza Vaccines Consumption by Type
5.3 Americas Avian Influenza Vaccines Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Avian Influenza Vaccines Consumption by Regions
6.1.1 APAC Avian Influenza Vaccines Consumption by Regions (2015-2020)
6.1.2 APAC Avian Influenza Vaccines Value by Regions (2015-2020)
6.2 APAC Avian Influenza Vaccines Consumption by Type
6.3 APAC Avian Influenza Vaccines Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Avian Influenza Vaccines by Countries
7.1.1 Europe Avian Influenza Vaccines Consumption by Countries (2015-2020)
7.1.2 Europe Avian Influenza Vaccines Value by Countries (2015-2020)
7.2 Europe Avian Influenza Vaccines Consumption by Type
7.3 Europe Avian Influenza Vaccines Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Avian Influenza Vaccines by Countries
8.1.1 Middle East & Africa Avian Influenza Vaccines Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Avian Influenza Vaccines Value by Countries (2015-2020)
8.2 Middle East & Africa Avian Influenza Vaccines Consumption by Type
8.3 Middle East & Africa Avian Influenza Vaccines Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Avian Influenza Vaccines Distributors
10.3 Avian Influenza Vaccines Customer

11 Global Avian Influenza Vaccines Market Forecast
11.1 Global Avian Influenza Vaccines Consumption Forecast (2021-2025)
11.2 Global Avian Influenza Vaccines Forecast by Regions
11.2.1 Global Avian Influenza Vaccines Forecast by Regions (2021-2025)
11.2.2 Global Avian Influenza Vaccines Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Avian Influenza Vaccines Forecast by Type
11.8 Global Avian Influenza Vaccines Forecast by Application

12 Key Players Analysis
12.1 Merial
12.1.1 Company Information
12.1.2 Avian Influenza Vaccines Product Offered
12.1.3 Merial Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Merial Latest Developments
12.2 CEVA
12.2.1 Company Information
12.2.2 Avian Influenza Vaccines Product Offered
12.2.3 CEVA Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 CEVA Latest Developments
12.3 Elanco (Lohmann )
12.3.1 Company Information
12.3.2 Avian Influenza Vaccines Product Offered
12.3.3 Elanco (Lohmann ) Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Elanco (Lohmann ) Latest Developments
12.4 Merck Animal Health
12.4.1 Company Information
12.4.2 Avian Influenza Vaccines Product Offered
12.4.3 Merck Animal Health Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Merck Animal Health Latest Developments
12.5 Zoetis
12.5.1 Company Information
12.5.2 Avian Influenza Vaccines Product Offered
12.5.3 Zoetis Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Zoetis Latest Developments
12.6 Avimex Animal Health
12.6.1 Company Information
12.6.2 Avian Influenza Vaccines Product Offered
12.6.3 Avimex Animal Health Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Avimex Animal Health Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Avian Influenza Vaccines Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Type H5
Table 5. Major Players of Type H9
Table 6. Major Players of Other
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Avian Influenza Vaccines Consumption Market Share by Type (2015-2020)
Table 9. Global Avian Influenza Vaccines Revenue by Type (2015-2020) ($ million)
Table 10. Global Avian Influenza Vaccines Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Avian Influenza Vaccines Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Avian Influenza Vaccines Consumption Market Share by Application (2015-2020)
Table 14. Global Avian Influenza Vaccines Value by Application (2015-2020)
Table 15. Global Avian Influenza Vaccines Value Market Share by Application (2015-2020)
Table 16. Global Avian Influenza Vaccines Sale Price by Application (2015-2020)
Table 17. Global Avian Influenza Vaccines Sales by Company (2017-2019) (M Doses)
Table 18. Global Avian Influenza Vaccines Sales Market Share by Company (2017-2019)
Table 19. Global Avian Influenza Vaccines Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Avian Influenza Vaccines Revenue Market Share by Company (2017-2019)
Table 21. Global Avian Influenza Vaccines Sale Price by Company (2017-2019)
Table 22. Global Avian Influenza Vaccines Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Avian Influenza Vaccines Products Offered
Table 24. Avian Influenza Vaccines Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Avian Influenza Vaccines Consumption by Regions 2015-2020 (M Doses)
Table 26. Global Avian Influenza Vaccines Consumption Market Share by Regions 2015-2020
Table 27. Global Avian Influenza Vaccines Value by Regions 2015-2020 ($ Millions)
Table 28. Global Avian Influenza Vaccines Value Market Share by Regions 2015-2020
Table 29. Americas Avian Influenza Vaccines Consumption by Countries (2015-2020) (M Doses)
Table 30. Americas Avian Influenza Vaccines Consumption Market Share by Countries (2015-2020)
Table 31. Americas Avian Influenza Vaccines Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Avian Influenza Vaccines Value Market Share by Countries (2015-2020)
Table 33. Americas Avian Influenza Vaccines Consumption by Type (2015-2020) (M Doses)
Table 34. Americas Avian Influenza Vaccines Consumption Market Share by Type (2015-2020)
Table 35. Americas Avian Influenza Vaccines Consumption by Application (2015-2020) (M Doses)
Table 36. Americas Avian Influenza Vaccines Consumption Market Share by Application (2015-2020)
Table 37. APAC Avian Influenza Vaccines Consumption by Countries (2015-2020) (M Doses)
Table 38. APAC Avian Influenza Vaccines Consumption Market Share by Countries (2015-2020)
Table 39. APAC Avian Influenza Vaccines Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Avian Influenza Vaccines Value Market Share by Regions (2015-2020)
Table 41. APAC Avian Influenza Vaccines Consumption by Type (2015-2020) (M Doses)
Table 42. APAC Avian Influenza Vaccines Consumption Market Share by Type (2015-2020)
Table 43. APAC Avian Influenza Vaccines Consumption by Application (2015-2020) (M Doses)
Table 44. APAC Avian Influenza Vaccines Consumption Market Share by Application (2015-2020)
Table 45. Europe Avian Influenza Vaccines Consumption by Countries (2015-2020) (M Doses)
Table 46. Europe Avian Influenza Vaccines Consumption Market Share by Countries (2015-2020)
Table 47. Europe Avian Influenza Vaccines Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Avian Influenza Vaccines Value Market Share by Countries (2015-2020)
Table 49. Europe Avian Influenza Vaccines Consumption by Type (2015-2020) (M Doses)
Table 50. Europe Avian Influenza Vaccines Consumption Market Share by Type (2015-2020)
Table 51. Europe Avian Influenza Vaccines Consumption by Application (2015-2020) (M Doses)
Table 52. Europe Avian Influenza Vaccines Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Avian Influenza Vaccines Consumption by Countries (2015-2020) (M Doses)
Table 54. Middle East & Africa Avian Influenza Vaccines Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Avian Influenza Vaccines Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Avian Influenza Vaccines Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Avian Influenza Vaccines Consumption by Type (2015-2020) (M Doses)
Table 58. Middle East & Africa Avian Influenza Vaccines Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Avian Influenza Vaccines Consumption by Application (2015-2020) (M Doses)
Table 60. Middle East & Africa Avian Influenza Vaccines Consumption Market Share by Application (2015-2020)
Table 61. Avian Influenza Vaccines Distributors List
Table 62. Avian Influenza Vaccines Customer List
Table 63. Global Avian Influenza Vaccines Consumption Forecast by Countries (2021-2025) (M Doses)
Table 64. Global Avian Influenza Vaccines Consumption Market Forecast by Regions
Table 65. Global Avian Influenza Vaccines Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Avian Influenza Vaccines Value Market Share Forecast by Regions
Table 67. Global Avian Influenza Vaccines Consumption Forecast by Type (2021-2025) (M Doses)
Table 68. Global Avian Influenza Vaccines Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Avian Influenza Vaccines Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Avian Influenza Vaccines Value Market Share Forecast by Type (2021-2025)
Table 71. Global Avian Influenza Vaccines Consumption Forecast by Application (2021-2025) (M Doses)
Table 72. Global Avian Influenza Vaccines Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Avian Influenza Vaccines Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Avian Influenza Vaccines Value Market Share Forecast by Application (2021-2025)
Table 75. Merial Product Offered
Table 76. Merial Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)
Table 77. Merial Main Business
Table 78. Merial Latest Developments
Table 79. Merial Basic Information, Company Total Revenue (in $ million), Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 80. CEVA Product Offered
Table 81. CEVA Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)
Table 82. CEVA Main Business
Table 83. CEVA Latest Developments
Table 84. CEVA Basic Information, Company Total Revenue (in $ million), Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 85. Elanco (Lohmann ) Product Offered
Table 86. Elanco (Lohmann ) Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)
Table 87. Elanco (Lohmann ) Main Business
Table 88. Elanco (Lohmann ) Latest Developments
Table 89. Elanco (Lohmann ) Basic Information, Company Total Revenue (in $ million), Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 90. Merck Animal Health Product Offered
Table 91. Merck Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)
Table 92. Merck Animal Health Main Business
Table 93. Merck Animal Health Latest Developments
Table 94. Merck Animal Health Basic Information, Company Total Revenue (in $ million), Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 95. Zoetis Product Offered
Table 96. Zoetis Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)
Table 97. Zoetis Main Business
Table 98. Zoetis Latest Developments
Table 99. Zoetis Basic Information, Company Total Revenue (in $ million), Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 100. Avimex Animal Health Product Offered
Table 101. Avimex Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)
Table 102. Avimex Animal Health Main Business
Table 103. Avimex Animal Health Latest Developments
Table 104. Avimex Animal Health Basic Information, Company Total Revenue (in $ million), Avian Influenza Vaccines Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Avian Influenza Vaccines
Figure 2. Avian Influenza Vaccines Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Avian Influenza Vaccines Consumption Growth Rate 2015-2025 (M Doses)
Figure 5. Global Avian Influenza Vaccines Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Type H5
Figure 7. Product Picture of Type H9
Figure 8. Product Picture of Other
Figure 9. Global Avian Influenza Vaccines Consumption Market Share by Type (2015-2020)
Figure 10. Global Avian Influenza Vaccines Value Market Share by Type (2015-2020)
Figure 11. Avian Influenza Vaccines Consumed in Chicken
Figure 12. Global Avian Influenza Vaccines Market: Chicken (2015-2020) (M Doses)
Figure 13. Global Avian Influenza Vaccines Market: Chicken (2015-2020) ($ Millions)
Figure 14. Avian Influenza Vaccines Consumed in Duck & Goose
Figure 15. Global Avian Influenza Vaccines Market: Duck & Goose (2015-2020) (M Doses)
Figure 16. Global Avian Influenza Vaccines Market: Duck & Goose (2015-2020) ($ Millions)
Figure 17. Avian Influenza Vaccines Consumed in Other
Figure 18. Global Avian Influenza Vaccines Market: Other (2015-2020) (M Doses)
Figure 19. Global Avian Influenza Vaccines Market: Other (2015-2020) ($ Millions)
Figure 20. Global Avian Influenza Vaccines Consumption Market Share by Application (2015-2020)
Figure 21. Global Avian Influenza Vaccines Value Market Share by Application (2015-2020)
Figure 22. Global Avian Influenza Vaccines Sales Market Share by Company in 2017
Figure 23. Global Avian Influenza Vaccines Sales Market Share by Company in 2019
Figure 24. Global Avian Influenza Vaccines Revenue Market Share by Company in 2017
Figure 25. Global Avian Influenza Vaccines Revenue Market Share by Company in 2019
Figure 26. Global Avian Influenza Vaccines Sale Price by Company in 2019
Figure 27. Global Avian Influenza Vaccines Consumption Market Share by Regions 2015-2020
Figure 28. Global Avian Influenza Vaccines Value Market Share by Regions 2015-2020
Figure 29. Americas Avian Influenza Vaccines Consumption 2015-2020 (M Doses)
Figure 30. Americas Avian Influenza Vaccines Value 2015-2020 ($ Millions)
Figure 31. APAC Avian Influenza Vaccines Consumption 2015-2020 (M Doses)
Figure 32. APAC Avian Influenza Vaccines Value 2015-2020 ($ Millions)
Figure 33. Europe Avian Influenza Vaccines Consumption 2015-2020 (M Doses)
Figure 34. Europe Avian Influenza Vaccines Value 2015-2020 ($ Millions)
Figure 35. Middle East & Africa Avian Influenza Vaccines Consumption 2015-2020 (M Doses)
Figure 36. Middle East & Africa Avian Influenza Vaccines Value 2015-2020 ($ Millions)
Figure 37. Americas Avian Influenza Vaccines Consumption Market Share by Countries in 2019
Figure 38. Americas Avian Influenza Vaccines Value Market Share by Countries in 2019
Figure 39. Americas Avian Influenza Vaccines Consumption Market Share by Type in 2019
Figure 40. Americas Avian Influenza Vaccines Consumption Market Share by Application in 2019
Figure 41. United States Avian Influenza Vaccines Consumption Growth 2015-2020 (M Doses)
Figure 42. United States Avian Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 43. Canada Avian Influenza Vaccines Consumption Growth 2015-2020 (M Doses)
Figure 44. Canada Avian Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 45. Mexico Avian Influenza Vaccines Consumption Growth 2015-2020 (M Doses)
Figure 46. Mexico Avian Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 47. APAC Avian Influenza Vaccines Consumption Market Share by Countries in 2019
Figure 48. APAC Avian Influenza Vaccines Value Market Share by Regions in 2019
Figure 49. APAC Avian Influenza Vaccines Consumption Market Share by Type in 2019
Figure 50. APAC Avian Influenza Vaccines Consumption Market Share by Application in 2019
Figure 51. China Avian Influenza Vaccines Consumption Growth 2015-2020 (M Doses)
Figure 52. China Avian Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 53. Japan Avian Influenza Vaccines Consumption Growth 2015-2020 (M Doses)
Figure 54. Japan Avian Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 55. Korea Avian Influenza Vaccines Consumption Growth 2015-2020 (M Doses)
Figure 56. Korea Avian Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 57. Southeast Asia Avian Influenza Vaccines Consumption Growth 2015-2020 (M Doses)
Figure 58. Southeast Asia Avian Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 59. India Avian Influenza Vaccines Consumption Growth 2015-2020 (M Doses)
Figure 60. India Avian Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 61. Australia Avian Influenza Vaccines Consumption Growth 2015-2020 (M Doses)
Figure 62. Australia Avian Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 63. Europe Avian Influenza Vaccines Consumption Market Share by Countries in 2019
Figure 64. Europe Avian Influenza Vaccines Value Market Share by Countries in 2019
Figure 65. Europe Avian Influenza Vaccines Consumption Market Share by Type in 2019
Figure 66. Europe Avian Influenza Vaccines Consumption Market Share by Application in 2019
Figure 67. Germany Avian Influenza Vaccines Consumption Growth 2015-2020 (M Doses)
Figure 68. Germany Avian Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 69. France Avian Influenza Vaccines Consumption Growth 2015-2020 (M Doses)
Figure 70. France Avian Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 71. UK Avian Influenza Vaccines Consumption Growth 2015-2020 (M Doses)
Figure 72. UK Avian Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 73. Italy Avian Influenza Vaccines Consumption Growth 2015-2020 (M Doses)
Figure 74. Italy Avian Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 75. Russia Avian Influenza Vaccines Consumption Growth 2015-2020 (M Doses)
Figure 76. Russia Avian Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 77. Middle East & Africa Avian Influenza Vaccines Consumption Market Share by Countries in 2019
Figure 78. Middle East & Africa Avian Influenza Vaccines Value Market Share by Countries in 2019
Figure 79. Middle East & Africa Avian Influenza Vaccines Consumption Market Share by Type in 2019
Figure 80. Middle East & Africa Avian Influenza Vaccines Consumption Market Share by Application in 2019
Figure 81. Egypt Avian Influenza Vaccines Consumption Growth 2015-2020 (M Doses)
Figure 82. Egypt Avian Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 83. South Africa Avian Influenza Vaccines Consumption Growth 2015-2020 (M Doses)
Figure 84. South Africa Avian Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 85. Israel Avian Influenza Vaccines Consumption Growth 2015-2020 (M Doses)
Figure 86. Israel Avian Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 87. Turkey Avian Influenza Vaccines Consumption Growth 2015-2020 (M Doses)
Figure 88. Turkey Avian Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 89. GCC Countries Avian Influenza Vaccines Consumption Growth 2015-2020 (M Doses)
Figure 90. GCC Countries Avian Influenza Vaccines Value Growth 2015-2020 ($ Millions)
Figure 91. Global Avian Influenza Vaccines Consumption Growth Rate Forecast (2021-2025) (M Doses)
Figure 92. Global Avian Influenza Vaccines Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 93. Americas Avian Influenza Vaccines Consumption 2021-2025 (M Doses)
Figure 94. Americas Avian Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 95. APAC Avian Influenza Vaccines Consumption 2021-2025 (M Doses)
Figure 96. APAC Avian Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 97. Europe Avian Influenza Vaccines Consumption 2021-2025 (M Doses)
Figure 98. Europe Avian Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 99. Middle East & Africa Avian Influenza Vaccines Consumption 2021-2025 (M Doses)
Figure 100. Middle East & Africa Avian Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 101. United States Avian Influenza Vaccines Consumption 2021-2025 (M Doses)
Figure 102. United States Avian Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 103. Canada Avian Influenza Vaccines Consumption 2021-2025 (M Doses)
Figure 104. Canada Avian Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 105. Mexico Avian Influenza Vaccines Consumption 2021-2025 (M Doses)
Figure 106. Mexico Avian Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 107. Brazil Avian Influenza Vaccines Consumption 2021-2025 (M Doses)
Figure 108. Brazil Avian Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 109. China Avian Influenza Vaccines Consumption 2021-2025 (M Doses)
Figure 110. China Avian Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 111. Japan Avian Influenza Vaccines Consumption 2021-2025 (M Doses)
Figure 112. Japan Avian Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 113. Korea Avian Influenza Vaccines Consumption 2021-2025 (M Doses)
Figure 114. Korea Avian Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 115. Southeast Asia Avian Influenza Vaccines Consumption 2021-2025 (M Doses)
Figure 116. Southeast Asia Avian Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 117. India Avian Influenza Vaccines Consumption 2021-2025 (M Doses)
Figure 118. India Avian Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 119. Australia Avian Influenza Vaccines Consumption 2021-2025 (M Doses)
Figure 120. Australia Avian Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 121. Germany Avian Influenza Vaccines Consumption 2021-2025 (M Doses)
Figure 122. Germany Avian Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 123. France Avian Influenza Vaccines Consumption 2021-2025 (M Doses)
Figure 124. France Avian Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 125. UK Avian Influenza Vaccines Consumption 2021-2025 (M Doses)
Figure 126. UK Avian Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 127. Italy Avian Influenza Vaccines Consumption 2021-2025 (M Doses)
Figure 128. Italy Avian Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 129. Russia Avian Influenza Vaccines Consumption 2021-2025 (M Doses)
Figure 130. Russia Avian Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 131. Spain Avian Influenza Vaccines Consumption 2021-2025 (M Doses)
Figure 132. Spain Avian Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 133. Egypt Avian Influenza Vaccines Consumption 2021-2025 (M Doses)
Figure 134. Egypt Avian Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 135. South Africa Avian Influenza Vaccines Consumption 2021-2025 (M Doses)
Figure 136. South Africa Avian Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 137. Israel Avian Influenza Vaccines Consumption 2021-2025 (M Doses)
Figure 138. Israel Avian Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 139. Turkey Avian Influenza Vaccines Consumption 2021-2025 (M Doses)
Figure 140. Turkey Avian Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 141. GCC Countries Avian Influenza Vaccines Consumption 2021-2025 (M Doses)
Figure 142. GCC Countries Avian Influenza Vaccines Value 2021-2025 ($ Millions)
Figure 143. Merial Avian Influenza Vaccines Market Share (2018-2020)
Figure 144. CEVA Avian Influenza Vaccines Market Share (2018-2020)
Figure 145. Elanco (Lohmann ) Avian Influenza Vaccines Market Share (2018-2020)
Figure 146. Merck Animal Health Avian Influenza Vaccines Market Share (2018-2020)
Figure 147. Zoetis Avian Influenza Vaccines Market Share (2018-2020)
Figure 148. Avimex Animal Health Avian Influenza Vaccines Market Share (2018-2020)
  • (Post-pandemic Era) - Global Meningococcal Vaccines Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
    Published: 24-Sep-2020        Price: US 3210 Onwards        Pages: 81
    Summary As the world continues to deal with COVID-19, economies are moving into recession, official counts of cases and deaths from COVID-19 have passed 4,000,000 and 280,000 at the time of this report. Many government announced a plan on reopening the national economy, but many countries are still at the stage of rising. On a more positive note, we are already seeing signs of recovery as the COVID-19 risk is declining in China. Chinese original equipment manufactur......
  • (Post-pandemic Era) - Global Meningococcal Vaccines Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
    Published: 24-Sep-2020        Price: US 3620 Onwards        Pages: 102
    Summary World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war. Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing glo......
  • (Post-pandemic Era) - Global Meningococcal Vaccines Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026
    Published: 24-Sep-2020        Price: US 3650 Onwards        Pages: 104
    Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly opt......
  • Global Encephalitis Vaccination Market Growth (Status and Outlook) 2020-2025
    Published: 22-Sep-2020        Price: US 3660 Onwards        Pages: 115
    According to this study, over the next five years the Encephalitis Vaccination market will register a 5.8%% CAGR in terms of revenue, the global market size will reach $ 1413.7 million by 2025, from $ 1127.9 million in 2019. In particular, this report presents the global revenue market share of key companies in Encephalitis Vaccination business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Encephalitis Vaccination m......
  • Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2020-2025
    Published: 21-Sep-2020        Price: US 3660 Onwards        Pages: 133
    According to this study, over the next five years the 23-Valent Pneumococcal Polysaccharide Vaccine market will register a 14.9%% CAGR in terms of revenue, the global market size will reach $ 3513.8 million by 2025, from $ 2013.3 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in 23-Valent Pneumococcal Polysaccharide Vaccine business, shared in Chapter 3. This report presents a comprehensive overview, market shares,......
  • COVID-19 World Influenza Vaccine Market Research Report (by Product Type, End-User / Application and Regions / Countries)
    Published: 19-Sep-2020        Price: US 2800 Onwards        Pages: 112
    Summary This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. The report includes as follows: The report provides current data, historical overview and future forecast. The report includes an in-depth analysis of the Global market for Influenza Vaccine , covering Global tota......
  • Global Avian Influenza Vaccines Market Growth 2020-2025
    Published: 16-Sep-2020        Price: US 3660 Onwards        Pages: 135
    According to this study, over the next five years the Avian Influenza Vaccines market will register a 2.5%% CAGR in terms of revenue, the global market size will reach $ 117.3 million by 2025, from $ 106.3 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Avian Influenza Vaccines business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Avian Influenza ......
  • 2020-2029 Report on Global Encephalitis Vaccination Market by Player, Region, Type, Application and Sales Channel
    Published: 14-Sep-2020        Price: US 2500 Onwards        Pages: 106
    The global Encephalitis Vaccination market was valued at $XX million in 2019, and MAResearch analysts predict the global market size will reach $XX million by the end of 2029, growing at a CAGR of XX% between 2020 and 2029. Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 210 countries and territories around the world and 2 international conveyances. The global impacts of COVID-19 are already starting to be felt, and will significantly affect this......
  • Global and Japan Pneumococcal Polysaccharide Vaccine Market Insights, Forecast to 2026
    Published: 11-Sep-2020        Price: US 3900 Onwards        Pages: 128
    Pneumococcal Polysaccharide Vaccine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Pneumococcal Polysaccharide Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026. Segment by Type, the P......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs